ask="7.20"
ask_size="700"
average_daily_volume="42118"
bid="4.02"
bid_size="100"
book_value="5.08"
change="+0.32"
change_from_200_day_moving_average="-0.38"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-7.49"
change_From_52_week_low="1.37"
change_in_percent="+6.48%"
close="5.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.45"
ex_dividend_date="N/A"
float_shares="6404000"
high="5.40"
high_52_weeks="12.75"
last_trade_date="1/6/2017"
last_trade_price="5.26"
last_trade_size="571"
last_trade_time="4:00pm"
low="4.79"
low_52_weeks="3.89"
market_capitalization="70.64M"
moving_average_200_day="5.64"
moving_average_50_day="5.28"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="16.33"
open="5.29"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-6.66%"
percent_change_from_50_day_moving_average="-0.33%"
percent_change_from_52_week_high="-58.75%"
percent_change_from_52_week_low="+35.22%"
previous_close="4.94"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.97"
price_per_sales="13.36"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.21"
stock_exchange="NGM"
symbol="AGLE"
volume="12889"
weeks_range_52="3.89 - 12.75"
